Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.

van Altena, R

Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis. [electronic resource] - Antimicrobial agents and chemotherapy 03 2017

Publication Type: Journal Article

1098-6596

10.1128/AAC.01400-16 doi


Adult
Amikacin--adverse effects
Antitubercular Agents--adverse effects
Area Under Curve
Audiometry
Biological Availability
Drug Administration Schedule
Drug Dosage Calculations
Drug Monitoring
Extensively Drug-Resistant Tuberculosis--blood
Female
Hearing Loss--chemically induced
Humans
Kanamycin--adverse effects
Male
Microbial Sensitivity Tests
Mycobacterium tuberculosis--drug effects
Retrospective Studies